What is HepatoChem?
HepatoChem, Inc. operates at the intersection of high-precision engineering and chemical synthesis, serving as a leading manufacturer of photochemistry reactors, specialized LEDs, and laboratory accessories. The company gained industry prominence through its flagship PhotoRedOx Box, a device widely recognized in peer-reviewed literature for its exceptional reproducibility and uniform irradiation of photochemical samples. Beyond its foundational technology, HepatoChem has systematically diversified its product portfolio to include the high-capacity PhotoRedOx Duo and the temperature-controlled PhotoRedOx Box TC, which facilitates complex reactions between 0 and 80 degrees Celsius. This technical versatility allows the firm to address the evolving needs of academic researchers and industrial chemists alike, positioning it as a critical infrastructure provider in the global transition toward more efficient, light-driven chemical processes.
How much funding has HepatoChem raised?
HepatoChem has raised a total of $61K across 1 funding round:
Debt
$61K
Debt (2021): $61K with participation from PPP
Key Investors in HepatoChem
PPP
Public-Private Partnership
What's next for HepatoChem?
With the recent influx of capital, HepatoChem is poised to transition from a specialized equipment provider to a broader industrial partner. The strategic focus will likely center on scaling manufacturing capacity to meet the rising demand for reproducible photochemical workflows in pharmaceutical and material science applications. Furthermore, the company is expected to invest in R&D to refine its temperature-controlled reactor series, potentially expanding its footprint into high-throughput industrial manufacturing environments. As the industry shifts toward sustainable, light-mediated synthesis, HepatoChem's ability to maintain rigorous standards of consistency will be the primary driver of its long-term competitive advantage and market expansion.
See full HepatoChem company page
